Just one place in Australia is hitting hepatitis B treatment targets — this is what it does

When Australia missed its target of treating 20% of chronic hepatitis B patients in 2022, there was one exception.
Even in 2023, the national treatment rate was just 12.6%, according to a report by the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and the Peter Doherty Institute for Infection and Immunity.
On current trajectories, Australia will take until 2047 to meet the target … 25 years late.
The exception is the South Western Sydney Primary Health Network (SWS PHN): the only one to meet the 20% target, with no other PHN predicted to join it until 2030.